Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Human Microbiome Based Drugs and Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Microbiome Based Drugs and Diagnosticsmarket, defines the market attractiveness level of Human Microbiome Based Drugs and Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Microbiome Based Drugs and Diagnostics industry, describes the types of Human Microbiome Based Drugs and Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Microbiome Based Drugs and Diagnostics market and the development prospects and opportunities of Human Microbiome Based Drugs and Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Microbiome Based Drugs and Diagnostics market in Chapter 13.
By Player:
Yakult
Enterome Bioscience
Osel
ViThera Pharmaceuticals
Merck
Second Genome
Vedanta BioSciences
MicroBiome Therapeutics
Metabiomics Corporation
DuPont
By Type:
Therapeutics
Diagnostics
By End-User:
Clinical Research Institutes
Hospital
Surgical Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Microbiome Based Drugs and Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Microbiome Based Drugs and Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Microbiome Based Drugs and Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Microbiome Based Drugs and Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Microbiome Based Drugs and Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global Human Microbiome Based Drugs and Diagnostics Consumption (2017-2022)
-
7.2 United States Human Microbiome Based Drugs and Diagnostics Consumption (2017-2022)
-
7.3 Europe Human Microbiome Based Drugs and Diagnostics Consumption (2017-2022)
-
7.4 China Human Microbiome Based Drugs and Diagnostics Consumption (2017-2022)
-
7.5 Japan Human Microbiome Based Drugs and Diagnostics Consumption (2017-2022)
-
7.6 India Human Microbiome Based Drugs and Diagnostics Consumption (2017-2022)
-
7.7 South Korea Human Microbiome Based Drugs and Diagnostics Consumption (2017-2022)
8 Region and Country-wise Human Microbiome Based Drugs and Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global Human Microbiome Based Drugs and Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States Human Microbiome Based Drugs and Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe Human Microbiome Based Drugs and Diagnostics Consumption Forecast (2022-2028)
-
8.4 China Human Microbiome Based Drugs and Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan Human Microbiome Based Drugs and Diagnostics Consumption Forecast (2022-2028)
-
8.6 India Human Microbiome Based Drugs and Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea Human Microbiome Based Drugs and Diagnostics Consumption Forecast (2022-2028)
9 Global Human Microbiome Based Drugs and Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Human Microbiome Based Drugs and Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Therapeutics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Diagnostics Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Microbiome Based Drugs and Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinical Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Human Microbiome Based Drugs and Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global Human Microbiome Based Drugs and Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Microbiome Based Drugs and Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinical Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Microbiome Based Drugs and Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Microbiome Based Drugs and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Microbiome Based Drugs and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Microbiome Based Drugs and Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Microbiome Based Drugs and Diagnostics Market Competitive Analysis
-
14.1 Yakult
-
14.1.1 Yakult Company Details
-
14.1.2 Yakult Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Yakult Human Microbiome Based Drugs and Diagnostics Product and Service
-
14.2 Enterome Bioscience
-
14.2.1 Enterome Bioscience Company Details
-
14.2.2 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product and Service
-
14.3 Osel
-
14.3.1 Osel Company Details
-
14.3.2 Osel Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Osel Human Microbiome Based Drugs and Diagnostics Product and Service
-
14.4 ViThera Pharmaceuticals
-
14.4.1 ViThera Pharmaceuticals Company Details
-
14.4.2 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Human Microbiome Based Drugs and Diagnostics Product and Service
-
14.6 Second Genome
-
14.6.1 Second Genome Company Details
-
14.6.2 Second Genome Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Second Genome Human Microbiome Based Drugs and Diagnostics Product and Service
-
14.7 Vedanta BioSciences
-
14.7.1 Vedanta BioSciences Company Details
-
14.7.2 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product and Service
-
14.8 MicroBiome Therapeutics
-
14.8.1 MicroBiome Therapeutics Company Details
-
14.8.2 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product and Service
-
14.9 Metabiomics Corporation
-
14.9.1 Metabiomics Corporation Company Details
-
14.9.2 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product and Service
-
14.10 DuPont
-
14.10.1 DuPont Company Details
-
14.10.2 DuPont Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 DuPont Human Microbiome Based Drugs and Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Microbiome Based Drugs and Diagnostics
-
Figure Human Microbiome Based Drugs and Diagnostics Picture
-
Table Global Human Microbiome Based Drugs and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Microbiome Based Drugs and Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Microbiome Based Drugs and Diagnostics Consumption by Country (2017-2022)
-
Figure United States Human Microbiome Based Drugs and Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Human Microbiome Based Drugs and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China Human Microbiome Based Drugs and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Microbiome Based Drugs and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Human Microbiome Based Drugs and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Microbiome Based Drugs and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Human Microbiome Based Drugs and Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Human Microbiome Based Drugs and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Microbiome Based Drugs and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Microbiome Based Drugs and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Microbiome Based Drugs and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Microbiome Based Drugs and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Microbiome Based Drugs and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Clinical Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinical Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Microbiome Based Drugs and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Microbiome Based Drugs and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table Yakult (Foundation Year, Company Profile and etc.)
-
Table Yakult Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yakult Human Microbiome Based Drugs and Diagnostics Product and Service
-
Table Enterome Bioscience (Foundation Year, Company Profile and etc.)
-
Table Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product and Service
-
Table Osel (Foundation Year, Company Profile and etc.)
-
Table Osel Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Osel Human Microbiome Based Drugs and Diagnostics Product and Service
-
Table ViThera Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Human Microbiome Based Drugs and Diagnostics Product and Service
-
Table Second Genome (Foundation Year, Company Profile and etc.)
-
Table Second Genome Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Second Genome Human Microbiome Based Drugs and Diagnostics Product and Service
-
Table Vedanta BioSciences (Foundation Year, Company Profile and etc.)
-
Table Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product and Service
-
Table MicroBiome Therapeutics (Foundation Year, Company Profile and etc.)
-
Table MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product and Service
-
Table Metabiomics Corporation (Foundation Year, Company Profile and etc.)
-
Table Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product and Service
-
Table DuPont (Foundation Year, Company Profile and etc.)
-
Table DuPont Human Microbiome Based Drugs and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table DuPont Human Microbiome Based Drugs and Diagnostics Product and Service
-
